Exact Mass: 205.1677848
Exact Mass Matches: 205.1677848
Found 274 metabolites which its exact mass value is equals to given mass value 205.1677848,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Panthenol
In cosmetics, panthenol (also called pantothenol) is a humectant, emollient, and moisturizer. It binds to hair follicles readily and is a frequent component of shampoos and hair conditioners (in concentrations of 0.1-1\\\%). It coats the hair and seals its surface, lubricating follicles and making strands appear shiny. Panthenol (specifically D-panthenol or dexpanthenol) is the alcohol analog of pantothenic acid (vitamin B5), and is thus the provitamin of B5. In organisms, it is quickly oxidized into pantothenate. Panthenol is a viscous transparent liquid at room temperature, but salts of pantothenic acid (for example sodium pantothenate) are powders (typically white). It is very soluble in water, alcohol, and propylene glycol, soluble in ether and chloroform, and only slightly soluble in glycerin. D - Dermatologicals > D03 - Preparations for treatment of wounds and ulcers > D03A - Cicatrizants A - Alimentary tract and metabolism > A11 - Vitamins S - Sensory organs > S01 - Ophthalmologicals Dietary supplement D-Panthenol is the biologically-active alcohol of pantothenic acid, which leads to an elevation in the amount of coenzyme A in the cell.
Diethylpropion
Diethylpropion is only found in individuals that have used or taken this drug. It is a appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)Diethylpropion is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppress hunger signals and appetite. Diethylpropion (through catecholamine elevation) may also indirectly affect leptin levels in the brain. It is theorized that diethylpropion can raise levels of leptin which signal satiety. It is also theorized that increased levels of the catecholamines are partially responsible for halting another chemical messenger known as neuropeptide Y. This peptide initiates eating, decreases energy expenditure, and increases fat storage. A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant
3-Hydroxy-N6,N6,N6-trimethyl-L-lysine
3-Hydroxy-N6,N6,N6-trimethyl-L-lysine is found within the Lysine degration pathway; it is the byproduct of trimethyllysine dioxygenase (EC 1.14.11.8) which converts N6-Hydroxy-trimethyl-lysine to Glycine and 4-Trimethyl-ammoniobutanal. Because carnitine is the final product of the Lysine degration pathway, this compound is often associated with carnitine defiency disorders. (PMID: 16707092) The compound is also a byproduct of glycine hydroxymethyltransferase (EC 2.1.2.1) and Lyases (EC 4.1.2.-). [HMDB] 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine is found within the Lysine degration pathway; it is the byproduct of trimethyllysine dioxygenase (EC 1.14.11.8) which converts N6-Hydroxy-trimethyl-lysine to Glycine and 4-Trimethyl-ammoniobutanal. Because carnitine is the final product of the Lysine degration pathway, this compound is often associated with carnitine defiency disorders. (PMID: 16707092) The compound is also a byproduct of glycine hydroxymethyltransferase (EC 2.1.2.1) and Lyases (EC 4.1.2.-).
Phenformin
A biguanide hypoglycemic agent with actions and uses similar to those of metformin. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BA - Biguanides C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98234 - Biguanide Antidiabetic Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides
N-Desthienylethyl-rotigotine
N-Desthienylethyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)
N,N-Diethyl-6-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-5-amine
trapidil
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
propan-2-one 4-benzyl-semicarbazone
C11H15N3O (205.12150599999998)
(5R,8R,8aS)-(-)-5-(4-pentynyl)-8-methylindolizidine|5-(pent-4-ynyl)-8-methylindolizidine|[5R,8R,8aS]-(-)-8-methyl-5-(pent-4-ynyl)octahydroindolizine
Panthenol
CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2048; ORIGINAL_PRECURSOR_SCAN_NO 2046 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2044; ORIGINAL_PRECURSOR_SCAN_NO 2041 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2041; ORIGINAL_PRECURSOR_SCAN_NO 2039 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2031; ORIGINAL_PRECURSOR_SCAN_NO 2029 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2045; ORIGINAL_PRECURSOR_SCAN_NO 2044 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2044; ORIGINAL_PRECURSOR_SCAN_NO 2042 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5225 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5228; ORIGINAL_PRECURSOR_SCAN_NO 5227 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5267; ORIGINAL_PRECURSOR_SCAN_NO 5265 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5263; ORIGINAL_PRECURSOR_SCAN_NO 5262 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5259; ORIGINAL_PRECURSOR_SCAN_NO 5258 CONFIDENCE standard compound; INTERNAL_ID 851; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5264; ORIGINAL_PRECURSOR_SCAN_NO 5262 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.228 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.226 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.221 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.222 D-Panthenol is the biologically-active alcohol of pantothenic acid, which leads to an elevation in the amount of coenzyme A in the cell.
PHENFORMIN
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BA - Biguanides C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98234 - Biguanide Antidiabetic Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5225 ORIGINAL_ACQUISITION_NO 5226; CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 5225 CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5228; ORIGINAL_PRECURSOR_SCAN_NO 5227 CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5267; ORIGINAL_PRECURSOR_SCAN_NO 5265 CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5263; ORIGINAL_PRECURSOR_SCAN_NO 5262 CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5259; ORIGINAL_PRECURSOR_SCAN_NO 5258 CONFIDENCE standard compound; INTERNAL_ID 210; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5264; ORIGINAL_PRECURSOR_SCAN_NO 5262
(5R,8R)-8-methyl-5-(pent-4-yn-1-yl)octahydroindolizine
(3S,5S,5aR,8aR)-3,5,7-trimethyl-2,2a,3,4,5,5a,6,8a-octahydro-1H-pyrrolo[2,1,5-de]quinolizine
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
1-(5-Methoxy-1H-pyrrolo[3,2-b]pyridin-3-yl)-N,N-dimethylmethanami ne
C11H15N3O (205.12150599999998)
N-(4-methylbenzyl)-N-(tetrahydro-2-furanylmethyl)amine
Piperazine-1-carboxylic acid phenylamide
C11H15N3O (205.12150599999998)
2-CIS-HYDROXYMETHYL-4-TRANS-PHENYL-1-CYCLOHEXYLAMINE
4-((DIMETHYLAMINO)METHYL)-2-METHYL-1H-BENZO[D]IMIDAZOL-5-OL
C11H15N3O (205.12150599999998)
1,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPTAN-2-ONE O-PROP-2-YNYL-OXIME
2-(4-Amino-2-methyl-5-nitrophenyl)amino]-ethanol
C11H15N3O (205.12150599999998)
((S)-1-((R)-1-PHENYLETHYL)PYRROLIDIN-3-YL)METHANOL
6-(4-METHYLPIPERAZIN-1-YL)NICOTINALDEHYDE
C11H15N3O (205.12150599999998)
(-)-(6-PROPYLAMINO)-5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-OL
1-[6-(1-Piperazinyl)-3-pyridinyl]ethanone
C11H15N3O (205.12150599999998)
tert-Butyl ((2R,3R)-1,3-dihydroxybutan-2-yl)carbamate
2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE
(3-Methyl-benzyl)-(tetrahydro-furan-2-ylmethyl)-amine
3-(Pentamethyldisiloxanyl)-1-propanamine
C8H23NOSi2 (205.13181079999998)
PIPERIDINE-4-CARBOXYLIC ACID PYRIDIN-3-YLAMIDE
C11H15N3O (205.12150599999998)
PIPERIDINE-3-CARBOXYLIC ACID PYRIDIN-3-YLAMIDE
C11H15N3O (205.12150599999998)
N-(PYRIDIN-2-YL)PIPERIDINE-4-CARBOXAMIDE
C11H15N3O (205.12150599999998)
N-pyridin-2-ylpiperidine-3-carboxamide
C11H15N3O (205.12150599999998)
(+)-(3R,4R)-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE
PIPERIDINE-3-CARBOXYLIC ACID PYRIDIN-4-YLAMIDE
C11H15N3O (205.12150599999998)
N-(4-Pyridinyl)-4-piperidinecarboxamide
C11H15N3O (205.12150599999998)
N-(5-isopropenyl-2-pyridyl)-2-methyl-propane-1,2-diamine
(5-ISOPROPYL-2-METHYLPHENOXY)ACETICACID
C11H15N3O (205.12150599999998)
Carbamic acid, (2-hydroxy-1,1-dimethylethoxy)-, 1,1-dimethylethyl ester (9CI)
((R)-1-((R)-1-PHENYLETHYL)PYRROLIDIN-3-YL)METHANOL
3-[(6-methyl-1H-benzimidazol-2-yl)amino]propan-1-ol
C11H15N3O (205.12150599999998)
1H-Imidazole-2-methanamine,1-methyl-N-[(1-methyl-1H-imidazol-4-yl)methyl]-(9CI)
7,9-Dimethyl-8-oxa-2-azaspiro[4.5]decane hydrochloride (1:1)
2-(diethylaminomethyl)cyclopentan-1-one,hydrochloride
N-Methyl-(4-phenyltetrahydropyran-4-yl)methylamine,
1-CYCLOHEXYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
1-(6-Methylpyrazin-2-yl)piperidine-3-carbaldehyde
C11H15N3O (205.12150599999998)
(1-METHYL-PIPERIDIN-4-YL)-PYRIDIN-3-YLMETHYL-AMINE
2-BENZYL-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID
C11H15N3O (205.12150599999998)
2-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)ethan-1-amine
2,2-Dimethyl-1-oxa-8-aza-spiro[4.5]decane hydrochloride
(2-METHYL-BENZYL)-(TETRAHYDRO-FURAN-2-YLMETHYL)-AMINE
N-METHYL-N-[(2-PIPERIDIN-1-YLPYRIDIN-4-YL)METHYL]AMINE
1-(6-methylpyrazin-2-yl)piperidine-4-carbaldehyde
C11H15N3O (205.12150599999998)
1-Naphthalenol, 5,6,7,8-tetrahydro-6-(propylamino)-
(2S,4S)-2-amino-6-(1-aminoethylideneamino)-4-fluorohexanoic acid
Trapidil
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
propanolamine
Propanolamine, also known as 3-amino-1-propanol, is a member of the class of compounds known as 1,3-aminoalcohols. 1,3-aminoalcohols are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C3 atom. Propanolamine is soluble (in water) and an extremely weak acidic compound (based on its pKa). Propanolamine can be found in french plantain, which makes propanolamine a potential biomarker for the consumption of this food product. Propanolamines include: Acebutolol Atenolol Betaxolol Bisoprolol Metoprolol Nadolol Penbutolol Phenylpropanolamine Pindolol Practolol Propranolol Ritodrine Timolol .
N-(3-methylbut-2-enyl)-1,4,5,7-tetrahydropurin-6-imine
(5-Amino-5-carboxy-4-hydroxy-pentyl)-trimethyl-ammonium
(2S)-2-[4-(2-methylpropyl)phenyl]propanoate
C13H17O2- (205.12284820000002)
(2R)-2-[4-(2-methylpropyl)phenyl]propanoate
C13H17O2- (205.12284820000002)
[(2S)-1-hydroxybutan-2-yl]-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethyl]azanium
2-[(1,5-Dimethyl-2-benzimidazolyl)amino]ethanol
C11H15N3O (205.12150599999998)
(Z)-[(4S)-4-amino-4-carboxybutyl]-[amino(methylamino)methylidene]-hydroxyazanium
[(4S)-4-amino-4-carboxybutyl]-[amino-(hydroxyamino)methylidene]-methylazanium
trans-2-Phenylcyclopropylamine, N-trimethylsilyl-
C12H19NSi (205.12866939999998)
Dexpanthenol
D - Dermatologicals > D03 - Preparations for treatment of wounds and ulcers > D03A - Cicatrizants A - Alimentary tract and metabolism > A11 - Vitamins S - Sensory organs > S01 - Ophthalmologicals D-Panthenol is the biologically-active alcohol of pantothenic acid, which leads to an elevation in the amount of coenzyme A in the cell.
Diethylpropion
A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant
1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one O-prop-2-ynyl-oxime
3-Hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine
The 3-hydroxy derivative of N(6),N(6),N(6)-trimethyl-L-lysine
3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine zwitterion
A proton-exchange tautomer of 3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine having an anionic carboxy group and a protonated amino group.
n-[2-(undeca-2,4,6,8-tetraen-1-ylidene)hydrazin-1-ylidene]hydroxylamine
C11H15N3O (205.12150599999998)